Clinical Trial Update: A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

View source ↗

Summary

This completed clinical trial evaluates the safety and effectiveness of Venetoclax for patients with chronic lymphocytic leukemia in routine clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Cancer, Chronic Lymphocytic Leukemia (CLL) | Status: COMPLETED